Veloxis Increases Share Capital in Connection with Exercise of Warrants
March 20, 2019 03:45 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 04/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 20 March 2019 Veloxis Increases Share Capital in Connection...
Notice to Convene Annual General Meeting 2019
March 12, 2019 12:59 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 03/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 12 March 2019 ...
Veloxis Pharmaceuticals Releases Annual Report for 2018
February 27, 2019 13:02 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 02/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 27 February 2019 Veloxis...
Veloxis to Host Conference Call Following Release of 2018 Annual Report
February 26, 2019 16:44 ET
|
Veloxis Pharmaceuticals A/S
Investor News no. 01/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 26 February 2019 Veloxis to Host Conference Call...
Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
January 02, 2019 18:49 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 01/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 January 2019 Mark Hensley Promoted to Chief Commercial...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
December 30, 2018 22:23 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 24/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2018 Veloxis Pharmaceuticals A/S Grants Warrants...
Veloxis Pharmaceuticals Announces Financial Calendar for 2019
December 28, 2018 17:12 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 23/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 December 2018 Veloxis...
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
December 19, 2018 16:20 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 22/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 December 2018 FDA Approves New Indication for ENVARSUS XR®...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 18, 2018 17:53 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 21/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 18 December 2018 Veloxis Increases Share Capital in...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 05, 2018 23:19 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 20/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 06 December 2018 Veloxis Increases Share Capital in Connection with...